Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Cash from Financing Activities (2018 - 2025)

Dna X (SONM) has disclosed Cash from Financing Activities for 8 consecutive years, with $7.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Financing Activities rose 51078.57% year-over-year to $7.2 million, compared with a TTM value of $19.1 million through Sep 2025, up 401.86%, and an annual FY2024 reading of $4.6 million, up 1608.09% over the prior year.
  • Cash from Financing Activities was $7.2 million for Q3 2025 at Dna X, up from $4.8 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $18.6 million in Q4 2021 and bottomed at -$37000.0 in Q1 2023.
  • Average Cash from Financing Activities over 5 years is $3.4 million, with a median of $382000.0 recorded in 2023.
  • The sharpest move saw Cash from Financing Activities skyrocketed 676200.0% in 2022, then crashed 511.11% in 2023.
  • Year by year, Cash from Financing Activities stood at $18.6 million in 2021, then plummeted by 100.19% to -$36000.0 in 2022, then fell by 2.78% to -$37000.0 in 2023, then soared by 2262.16% to $800000.0 in 2024, then soared by 795.62% to $7.2 million in 2025.
  • Business Quant data shows Cash from Financing Activities for SONM at $7.2 million in Q3 2025, $4.8 million in Q2 2025, and $6.4 million in Q1 2025.